The Money Spinner: $10 Billion TATA - Haldiram's Deal

Nirma's Glenmark Life Sciences Deal for $680 Million: Strategic Move into Pharma

TATA's Acquisition of Ching's: Not a Ka-Ching Moment!

Barbeque Nation: A Secret $5Billion CDR Company Taking On QSR in India

Bloomberg's TATA Assessment: Correct Conclusion, Constrained Content

2023 And Beyond: Premiumisation & Decentralisation

So Why Do We Write A Newsletter?

Decoding The Playbook For Generating Stellar Returns In India’s IPO Market

Shifting Fortunes: How Joe Biden's China Investment Ban Is Set to Propel India's Private Markets

M&M’s Investment In RBL Bank: How Not To Do Capital Allocation

Investment Tear Sheet: India's B2B Database Businesses

The Blackstone-Cipla Deal: Platforms The Holy Grail Of India Investments

India's Missing Middle 'Platforms': Unveiling the Untapped Goldmine That Could Change Everything!

The BYJU’S - Aakash Saga Tells Us? Education Is Big Business In India

Decoding AltG's Investment Criteria for Allocating a Billion Dollars In India

Indian Corporate Carve-Outs: Why Major Companies are Spinning Off to Soar to New Heights!

Venture Debt In Indian Startups: The Valley Of Death Or The Promised Land?

The Top 3 Trends Private Equity Should Be Watching in H2 2023

The PharmEasy Saga: An SOS Call and A Billionaire's Low Ball

The Great Indian Startup Sale: Offline Assets Are The Holy Grail